Page last updated: 2024-09-04

atrasentan and deoxypyridinoline

atrasentan has been researched along with deoxypyridinoline in 1 studies

Compound Research Comparison

Studies (atrasentan)	Trials (atrasentan)	Recent Studies (post-2010) (atrasentan)	Studies (deoxypyridinoline)	Trials (deoxypyridinoline)	Recent Studies (post-2010) (deoxypyridinoline)
358	41	108	1,364	261	143

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breul, J; Carducci, MA; Daliani, DD; Nabulsi, AA; Nelson, JB; Schulman, CC; Vogelzang, NJ; Zonnenberg, BA	1

Trials

1 trial(s) available for atrasentan and deoxypyridinoline

Article	Year
Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan. The Journal of urology, 2003, Volume: 169, Issue:3 Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Atrasentan; Biomarkers, Tumor; Bone Remodeling; Bone Resorption; Collagen; Collagen Type I; Double-Blind Method; Endothelin-1; Humans; Male; Peptides; Prostatic Neoplasms; Pyrrolidines	2003

Article

Year

Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan.

The Journal of urology, 2003, Volume: 169, Issue:3

Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Atrasentan; Biomarkers, Tumor; Bone Remodeling; Bone Resorption; Collagen; Collagen Type I; Double-Blind Method; Endothelin-1; Humans; Male; Peptides; Prostatic Neoplasms; Pyrrolidines

2003